Nintedanib

Last Updated: 09/19/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2360 publications

Comparative Clinical Outcomes of Nintedanib and Pirfenidone in Idiopathic Pulmonary Fibrosis: A Five-year Real-life Study.

Comparative Clinical Outcomes of Nintedanib and Pirfenidone in Idiopathic Pulmonary Fibrosis: A Five-year Real-life Study.

Journal: Thoracic research and practice

Published: September 04, 2026

Patient-reported adverse events and management of antifibrotic therapy in IPF: A multicenter, cross-sectional real-world study.

Patient-reported adverse events and management of antifibrotic therapy in IPF: A multicenter, cross-sectional real-world study.

Journal: Therapeutic advances in respiratory disease

Published: August 31, 2026

Erratum to: Combination therapy with mycophenolate mofetil, nintedanib, and tocilizumab in a patient with progressive systemic sclerosis-associated interstitial lung disease.

Erratum to: Combination therapy with mycophenolate mofetil, nintedanib, and tocilizumab in a patient with progressive systemic sclerosis-associated interstitial lung disease.

Journal: Zeitschrift fur Rheumatologie

Published: August 26, 2026

Prognostic nutritional index predicts nintedanib outcomes in idiopathic pulmonary fibrosis.

Prognostic nutritional index predicts nintedanib outcomes in idiopathic pulmonary fibrosis.

Journal: Therapeutic advances in respiratory disease

Published: August 12, 2026

Body composition is associated with nintedanib-related diarrhoea: risk stratification in idiopathic pulmonary fibrosis.

Body composition is associated with nintedanib-related diarrhoea: risk stratification in idiopathic pulmonary fibrosis.

Journal: Thorax

Published: August 07, 2026

Chinese expert consensus on the diagnosis and treatment of pneumoconiosis complicated with tuberculosis

Chinese expert consensus on the diagnosis and treatment of pneumoconiosis complicated with tuberculosis

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases

Published: August 05, 2026

Lung organoids as emerging models in idiopathic pulmonary fibrosis research: Current applications, challenges, and future directions.

Lung organoids as emerging models in idiopathic pulmonary fibrosis research: Current applications, challenges, and future directions.

Journal: Therapeutic advances in respiratory disease

Published: August 04, 2026

Tolerability and Safety of Nintedanib and Immunosuppression in Autoimmune Inflammatory Myopathy-Associated Progressive Pulmonary Fibrosis.

Tolerability and Safety of Nintedanib and Immunosuppression in Autoimmune Inflammatory Myopathy-Associated Progressive Pulmonary Fibrosis.

Journal: CHEST pulmonary

Published: August 04, 2026

Navigating the Challenges of Treating Autoimmune-Inflammatory Myopathy-Related Interstitial Lung Disease With Nintedanib.

Navigating the Challenges of Treating Autoimmune-Inflammatory Myopathy-Related Interstitial Lung Disease With Nintedanib.

Journal: CHEST pulmonary

Published: August 04, 2026

Precision Modulation of the PDE4 Pathway: The Emerging Role of Nerandomilast in Pulmonary Fibrosis.

Precision Modulation of the PDE4 Pathway: The Emerging Role of Nerandomilast in Pulmonary Fibrosis.

Journal: The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians

Published: July 23, 2026

High-oxygen gas-permeable culture improves viability and supports quantitative antifibrotic pharmacology in precision-cut liver slices.

High-oxygen gas-permeable culture improves viability and supports quantitative antifibrotic pharmacology in precision-cut liver slices.

Journal: American journal of physiology. Gastrointestinal and liver physiology

Published: July 15, 2026

Novel VHL ligand-based PROTACs targeting JNK1: design, synthesis, and biological evaluation with potent anti-EMT activity.

Novel VHL ligand-based PROTACs targeting JNK1: design, synthesis, and biological evaluation with potent anti-EMT activity.

Journal: Bioorganic chemistry

Published: July 08, 2026

Showing 1-12 of 2,360

Last Updated: 09/19/2026